EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential changes in cyclic adenosine 3′‐5′ monophosphate ( cAMP ) effectors and major Ca 2+ handling proteins during diabetic cardiomyopathy

Victoria Chaoul, Rita Hanna, Pia Hachem, Magali Samia El Hayek, Wared Nour-Eldine iD, Pamela Abou-Khalil, Elias Abi-Ramia, Grégoire Vandecasteele iD, Aniella Abi-Gerges iD

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Victoria Chaoul und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, P.O. Box 36, Byblos, Lebanon. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Conseil National de la Recherche Scientifique, Lebanese American University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic cardiomyopathy (DCM) is associated with differential and time‐specific regulation of β‐adrenergic receptors and cardiac cyclic nucleotide phosphodiesterases with consequences for total cyclic adenosine 3′‐5′ monophosphate (cAMP) levels. We aimed to investigate whether these changes are associated with downstream impairments in cAMP and Ca 2+ signalling in a type 1 diabetes (T1D)‐induced DCM model. T1D was induced in adult male rats by streptozotocin (65 mg/kg) injection. DCM was assessed by cardiac structural and molecular remodelling. We delineated sequential changes affecting the exchange protein (Epac1/2), cAMP‐dependent protein kinase A (PKA) and Ca 2+ /Calmodulin‐dependent kinase II (CaMKII) at 4, 8 and 12 weeks following diabetes, by real‐time quantitative PCR and western blot. Expression of Ca 2+ ATPase pump (SERCA2a), phospholamban (PLB) and Troponin I (TnI) was also examined. Early upregulation of Epac1 transcripts was noted in diabetic hearts at Week 4, followed by increases in Epac2 mRNA, but not protein levels, at Week 12. Expression of PKA subunits (RI, RIIα and Cα) remained unchanged regardless of the disease stage, whereas CaMKII increased at Week 12 in DCM. Moreover, PLB transcripts were upregulated in diabetic hearts, whereas SERCA2a and TnI gene expression was unchanged irrespective of the disease evolution. PLB phosphorylation at threonine‐17 was increased in DCM, whereas phosphorylation of both PLB at serine‐16 and TnI at serine‐23/24 was unchanged. We show for the first time differential and time‐specific regulations in cardiac cAMP effectors and Ca 2+ handling proteins, data that may prove useful in proposing new therapeutic approaches in T1D‐induced DCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesDiabetes Mellitus, Type 1MaleRatsAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium-Binding ProteinsTroponin IPhosphorylationSerineAdenosineMyocardium

Stichwörter der Autor:innen

Ca2+/calmodulin-dependent kinase IIcAMP-dependent protein kinasediabetic cardiomyopathyexchange protein directly activated by cAMPexcitation-contraction couplingtype 1 diabetes

Substanzen

Calcium-Calmodulin-Dependent Protein Kinase Type 2Calcium-Binding ProteinsTroponin ISerineAdenosine

Autor:innen und Institutionen

  • Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, P.O. Box 36, Byblos, Lebanon.
  • Signaling and Cardiovascular Pathophysiology, UMR-S1180, Université Paris-Saclay, Orsay, 91400, France.
  • School of Arts and Sciences, Department of Natural Sciences, Lebanese American University, Byblos, Lebanon.

ORCID-Profile: Wared Nour-Eldine, Grégoire Vandecasteele, Aniella Abi-Gerges

Förderung

  • Agence Nationale de la Recherche
  • Conseil National de la Recherche Scientifique
  • Lebanese American University
  • Providence Health Care

Zitieren

APA

Chaoul, V., Hanna, R., Hachem, P., El Hayek, M. S., Nour-Eldine, W., Abou-Khalil, P., Abi-Ramia, E., Vandecasteele, G., & Abi-Gerges, A. (2023). Differential changes in cyclic adenosine 3′‐5′ monophosphate ( cAMP ) effectors and major Ca 2+ handling proteins during diabetic cardiomyopathy. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17733

Vancouver

Chaoul V, Hanna R, Hachem P, El Hayek MS, Nour-Eldine W, Abou-Khalil P, et al. Differential changes in cyclic adenosine 3′‐5′ monophosphate ( cAMP ) effectors and major Ca 2+ handling proteins during diabetic cardiomyopathy. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17733

BibTeX
@article{Chaoul2023,
  author = {Chaoul, Victoria and Hanna, Rita and Hachem, Pia and El Hayek, Magali Samia and Nour-Eldine, Wared and Abou-Khalil, Pamela and Abi-Ramia, Elias and Vandecasteele, Grégoire and Abi-Gerges, Aniella},
  title = {Differential changes in cyclic adenosine 3′‐5′ monophosphate ( cAMP ) effectors and major Ca 2+ handling proteins during diabetic cardiomyopathy},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17733}
}
Kostenlos starten →